The Board resolution dated March 25, 2021, the BOD of BenTre Pharmaceutical Joint Stock Company approved the business plan in 2021 to submit to the General Meeting of Shareholders as follows:
Content
Unit
Parent company
Consolidated
Performance in 2020
Plan for 2021
% compared to Performance in 2020
Revenue
VND billion
806.0
792.8
98%
842.5
918.2
109%
Profit before tax
14.7
22.2
151%
18.7
23.5
126%
Profit after tax
11.2
18.4
164%
13.3
19.4
146%
Dividend
%
7%
20% (*)
(*) to pay cash or stock dividend, minimax 7% in cash.